Bioprocess Engineering of Mammalian Cell Culture

哺乳动物细胞培养的生物过程工程

• 批准号: RGPIN-2015-03736
• 负责人: Piret, James
• 金额: $ 2.91万
• 依托单位: University of British Columbia
• 依托单位国家: 加拿大
• 项目类别: Discovery Grants Program - Individual
• 财政年份: 2017
• 资助国家: 加拿大
• 起止时间: 2017-01-01 至 2018-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=637957
• 关键词: Bioprocess; Engineering; Mammalian; Cell; Culture

Mammalian cell cultures have become the dominant technology for the production of biological therapeutics. These cultures are also increasingly used for the research and development of novel immunotherapies and stem cell therapies, used to treat injuries and chronic diseases. The great promise of these emerging treatments comes with great challenges, many of those in the field of cell culture process engineering.

哺乳动物细胞培养已成为生物治疗药物生产的主导技术。这些培养物也越来越多地用于新型免疫疗法和干细胞疗法的研究和开发，用于治疗损伤和慢性疾病。这些新兴疗法的巨大前景也伴随着巨大的挑战，其中许多挑战是在细胞培养过程工程领域。